Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Drug alert number:EL (23)A/37 Date issued: 27 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Company name: Max Remedies Ltd
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/09/2023) announced the following list of price concessions for September 2023: Drug Pack size Price concession Atomoxetine 10mg capsules 28 £44.45 Atomoxetine 18mg capsules 28 £42.95 Atomoxetine 25mg
Read moreNational Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. National Patient Safety Alert Reference Number: NatPSA/2023/011/DHSC Date issued: 27th September 2023 Brief description of the problem There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity
Read moreThe October 2023 Drug Tariff has been updated to include a deadline for submission of any outstanding referred back prescriptions to the NHS Business Services Authority (NHSBSA) for payment. All prescriptions that have been referred-back must be completed and returned to the NHSBSA no later than 18 months from the date they are first sent
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item
Read moreA disallowed item is one that has NOT been passed for payment by the NHS Business Services Authority (NHSBSA). Please check your disallowed items history on Manage Your Service (MYS) portal to identify the list of unpaid items and reasons why the item was disallowed by the NHSBSA. If you believe an item has been
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 2 September 2023) has been published and includes articles on: Statins: very infrequent reports of myasthenia gravis Fluoroquinolone antibiotics: suicidal thoughts and behaviour Letters and medicine recalls sent to healthcare professionals in August 2023. To see the latest MHRA Drug
Read moreThe Drug Tariff Category M pricelist for October 2023 has been published on the NHS Business Services Authority (NHSBSA) website. At the end of Q4 2022/23 there remains an over delivery of medicine margin. The October Category M pricelist includes: Adjustments for underlying market price movements in the reference period April-June 2023. Of particular note is
Read morePharmacy press As today marks World Pharmacists Day, an annual awareness day led by the International Pharmaceutical Federation (FIP) – we, at Community Pharmacy England, celebrating the crucial role pharmacists play in improving access to healthcare, ensuring the responsible use of medicines and so much more. This year’s theme, ‘Pharmacy strengthening health systems’, highlights the
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be
Read more
